These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 25551903

  • 1. Left atrial appendage thrombus with resulting stroke post-RF ablation for atrial fibrillation in a patient on dabigatran.
    Lobo R, McCann C, Hussaini A, Meany TB, Kiernan TJ.
    Ir Med J; 2014; 107(10):329-30. PubMed ID: 25551903
    [Abstract] [Full Text] [Related]

  • 2. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
    Maddox W, Kay GN, Yamada T, Osorio J, Doppalapudi H, Plumb VJ, Gunter A, McElderry HT.
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):861-5. PubMed ID: 23577951
    [Abstract] [Full Text] [Related]

  • 3. Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity.
    Dager WE, Gosselin RC, Roberts AJ.
    Crit Care Med; 2013 May; 41(5):e42-6. PubMed ID: 23474679
    [Abstract] [Full Text] [Related]

  • 4. Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation.
    Sardar P, Nairooz R, Chatterjee S, Wetterslev J, Ghosh J, Aronow WS.
    Am J Cardiol; 2014 Apr 01; 113(7):1173-7. PubMed ID: 24513472
    [Abstract] [Full Text] [Related]

  • 5. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
    Kaiser DW, Streur MM, Nagarakanti R, Whalen SP, Ellis CR.
    J Interv Card Electrophysiol; 2013 Sep 01; 37(3):241-7. PubMed ID: 23625091
    [Abstract] [Full Text] [Related]

  • 6. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
    Uchiyama S, Ibayashi S, Matsumoto M, Nagao T, Nagata K, Nakagawara J, Tanahashi N, Tanaka K, Toyoda K, Yasaka M.
    J Stroke Cerebrovasc Dis; 2012 Apr 01; 21(3):165-73. PubMed ID: 22440950
    [Abstract] [Full Text] [Related]

  • 7. Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
    Lin C, Quan J, Bao Y, Hua W, Ke M, Zhang N, Jin Q, Xie Y, Wei Y, Ling T, Pan W, Wu L, Xie Y.
    J Cardiovasc Electrophysiol; 2020 Mar 01; 31(3):658-663. PubMed ID: 31975470
    [Abstract] [Full Text] [Related]

  • 8. Periprocedural dabigatran in atrial fibrillation ablation: a new kid on the block.
    Pelargonio G, Perna F.
    J Cardiovasc Electrophysiol; 2013 Aug 01; 24(8):866-8. PubMed ID: 23647979
    [No Abstract] [Full Text] [Related]

  • 9. Dabigatran for stroke prevention in atrial fibrillation.
    Hohnloser SH, Diener HC.
    Hamostaseologie; 2012 Aug 01; 32(3):216-20. PubMed ID: 22739760
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Kaseno K, Naito S, Nakamura K, Sakamoto T, Sasaki T, Tsukada N, Hayano M, Nishiuchi S, Fuke E, Miki Y, Nakamura K, Yamashita E, Kumagai K, Oshima S, Tada H.
    Circ J; 2012 Aug 01; 76(10):2337-42. PubMed ID: 22785434
    [Abstract] [Full Text] [Related]

  • 11. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L, Chen C, White J.
    Consult Pharm; 2014 Mar 01; 29(3):169-78. PubMed ID: 24589766
    [Abstract] [Full Text] [Related]

  • 12. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Providência R, Marijon E, Albenque JP, Combes S, Combes N, Jourda F, Hireche H, Morais J, Boveda S.
    Europace; 2014 Aug 01; 16(8):1137-44. PubMed ID: 24550347
    [Abstract] [Full Text] [Related]

  • 13. Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies.
    Steinberg BA, Hasselblad V, Atwater BD, Bahnson TD, Washam JB, Alexander JH, Daubert JP, Piccini JP.
    J Interv Card Electrophysiol; 2013 Sep 01; 37(3):213-21. PubMed ID: 23881249
    [Abstract] [Full Text] [Related]

  • 14. [Percutaneous left atrial appendage closure after resolution of left atrial appendage thrombi with dabigatran].
    Kis Z, Földesi C, Pál M, Som Z, Csillik A, Abrahám P, Temesvári A, Fontos G, Szatmári A, Andréka P, Kardos A.
    Orv Hetil; 2013 Feb 17; 154(7):262-5. PubMed ID: 23395790
    [Abstract] [Full Text] [Related]

  • 15. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
    Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S.
    Circulation; 2013 Jul 16; 128(3):237-43. PubMed ID: 23770747
    [Abstract] [Full Text] [Related]

  • 16. The peri-procedural use of dabigatran in patients undergoing left atrial ablation for atrial fibrillation.
    Somani R, Mohajer K, Haley C, Simpson CS, Abdollah H, Baranchuk A, Redfearn DP, Michael K.
    Cardiovasc Ther; 2014 Oct 16; 32(5):198-201. PubMed ID: 24889271
    [Abstract] [Full Text] [Related]

  • 17. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
    Chevalier J, Giroud M, de Pouvourville G.
    Cerebrovasc Dis; 2013 Oct 16; 35(4):320-6. PubMed ID: 23615428
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation.
    Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S.
    Clin Drug Investig; 2013 Jun 16; 33(6):409-18. PubMed ID: 23572324
    [Abstract] [Full Text] [Related]

  • 19. New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.
    Dahl OE.
    Vasc Health Risk Manag; 2012 Jun 16; 8():45-57. PubMed ID: 22323896
    [Abstract] [Full Text] [Related]

  • 20. [Dabigatran in the prevention of stroke in nonvalvular atrial fibrillation: complex clinical situations and real clinical practice].
    Tkacheva ON, Akasheva DU.
    Ter Arkh; 2014 Jun 16; 86(4):103-7. PubMed ID: 24864477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.